KISCO
VC Fund
Osaka, Japan
KISCO is a VC fund in Osaka focused on Medical and Health Care. KISCO engages in the sales of synthetic resins, chemicals, electronics materials, and packaging materials. KISCO offers domestic demand import and export services. KISCO Corporation was founded in 1921 and is based in Osaka, Japan.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries KISCO invests in
Stages KISCO invests in
Countries KISCO invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Medical 3 (50%)
- Health Care 3 (50%)
- Nursing and Residential Care 3 (50%)
- Biotechnology 2 (33%)
- Energy 1 (17%)
Stage
- Series A 2 (33%)
- Seed 1 (17%)
- Series B 1 (17%)
- Series D 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Koichi Kishimoto
President and CEO
|
President and CEO | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Gaudi Clinical is a health care firm that engages in regenerative medicine outsourcing and cell processing contract establishments. | $8.9M / Series A / Feb 07, 2025 | ||
| United Immunity is a research, development, manufacture and sale of pharmaceuticals, mainly for cancer immunotherapy. | $4.5M / Series B / Sep 07, 2021 | ||
| J-Pharma’s mission is to help mankind by creating and developing novel pharmaceuticals based upon a human-genomic approach; an approach where people with specific diseases are treated with novel and selective agents. J-Pharma’s intellectual property (IP) embraces the notion that cell membrane transporters are tightly associated to many diseases. Inaddition to drug molecules that target specific transporters, J-Pharma has discovered several important drug transporters within the human body that may be used to evaluate and optimize pharmacokinetics of new drug candidates. We believe that J-Pharma’s pipelines will lead to new agents and processes (i.e. diagnostic methods) and will increase the quality of life for an ageing population in industrialized countries. J-Pharma’s overall goal is to contribute globally to the maintenance of human health and improve human welfare through the creation of new drugs. | $16.7M / Series D / Jul 30, 2020 | ||
| EditForce develops drugs and seeds by using nucleic acid (DNA/RNA) manipulation technologies. | $24.8M / Seed / Feb 03, 2016 | ||
| Seven Dreamers Laboratories is the maker of personal-use devices dedicated to creating totally novel, world-first products. The company develops carbon tool, medical equipment with haute couture design, and a household laundry robot. It targets to commercialize the Laundroid, a laundry-folding robot that uses image-recognition algorithms and techto identify types of clothing, such as t-shirts, towels, and pants, fold each one appropriately, and sort them by item or family member.The company was founded in 2011 and is based in Tokyo, Japan. | $212.6M / Series A / Jun 08, 2015 | ||
| See all 6 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does KISCO invest in?
KISCO invests primarily in Medical, Health Care and Nursing and Residential Care startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact KISCO?
Public channels for KISCO include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at KISCO?
The team at KISCO includes Koichi Kishimoto (President and CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
